fhe-miR-125b: A Potential Therapeutic Target for Inflammatory Bowel Disease (IBD)

TargetScan analysis predicts that fhe-miR-125b-5 binds to the 3'-UTRs of TRAF6, MAP2K7, and STAT3 molecules. This suggests that fhe-miR-125b can bind to target genes associated with inflammation or IBD, including TRAF6, MAP2K7, and STAT3, to exert immune inhibitory effects. These findings indicate fhe-miR-125b's potential for the treatment of IBD.